On September 25, it was announced that medial device maker Stryker Corporation agreed to acquire all of the outstanding shares of MAKO Surgical Corp. for $30.00 per share in cash, an aggregate purchase price of approximately $1.65 billion. Willkie represented Citigroup Inc., Stryker’s financial adviser, in the transaction.
Based in Kalamazoo, Mich., Stryker is one of the world’s leading medical technology companies offering a diverse array of innovative medical technologies including reconstructive implants, medical and surgical equipment, and neurotechnology and spine products. Based in Ft. Lauderdale, Fla., MAKO Surgical markets its RIO® Robotic-Arm Interactive Orthopedic system, joint specific applications for the knee and hip, and proprietary RESTORIS® implants for orthopedic procedures called MAKOplasty®.
The deal was handled by partners Steven Seidman and Laura Delanoy and associate Marit Spekman.
